There’s a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Semtech (SMTC – Research Report), HashiCorp (HCP – Research Report) and Guidewire (GWRE – Research Report) with bullish sentiments.
Semtech (SMTC)
In a report released yesterday, Tore Svanberg from Stifel Nicolaus maintained a Buy rating on Semtech, with a price target of $22.00. The company’s shares closed last Monday at $20.62.
According to TipRanks.com, Svanberg is a top 100 analyst with an average return of
Semtech has an analyst consensus of Strong Buy, with a price target consensus of $30.64, representing a 53.0% upside. In a report issued on December 7, Needham also maintained a Buy rating on the stock with a $26.00 price target.
See today’s best-performing stocks on TipRanks >>
HashiCorp (HCP)
Stifel Nicolaus analyst Brad Reback maintained a Buy rating on HashiCorp yesterday and set a price target of $26.00. The company’s shares closed last Monday at $21.29, close to its 52-week low of $18.91.
According to TipRanks.com, Reback is a 5-star analyst with an average return of
Currently, the analyst consensus on HashiCorp is a Moderate Buy with an average price target of $26.00, implying a 24.7% upside from current levels. In a report issued on December 7, BTIG also maintained a Buy rating on the stock with a $25.00 price target.
Guidewire (GWRE)
In a report released yesterday, J. Parker Lane from Stifel Nicolaus maintained a Buy rating on Guidewire, with a price target of $110.00. The company’s shares closed last Monday at $96.26, close to its 52-week high of $102.41.
According to TipRanks.com, Lane is a 1-star analyst with an average return of
Guidewire has an analyst consensus of Moderate Buy, with a price target consensus of $111.33, implying a 14.7% upside from current levels. In a report issued on November 29, D.A. Davidson also maintained a Buy rating on the stock with a $126.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on SMTC:
- Short Report: Eyepoint Pharmaceuticals bears cut bait after Phase 2 trial data
- Semtech price target lowered to $25 from $32 at Northland
- Semtech price target lowered to $22 from $24 at Stifel
- Semtech price target lowered to $26 from $35 at Needham
- Semtech jumps 12% to $18.75 after Q3 earnings beat and guiance
